advertisement

Topcon

Journal of nanobiotechnology 9

Showing records 1 to 9 | Display all abstracts in Journal of nanobiotechnology

106177 Towards preventing exfoliation glaucoma by targeting and removing fibrillar aggregates associated with exfoliation syndrome
Ghaffari Sharaf M
Journal of nanobiotechnology 2022; 20: 459
106451 Immune modulating nanoparticles for the treatment of ocular diseases
Fang L
Journal of nanobiotechnology 2022; 20: 496
106177 Towards preventing exfoliation glaucoma by targeting and removing fibrillar aggregates associated with exfoliation syndrome
Waduthanthri KD
Journal of nanobiotechnology 2022; 20: 459
106451 Immune modulating nanoparticles for the treatment of ocular diseases
Liu J
Journal of nanobiotechnology 2022; 20: 496
106177 Towards preventing exfoliation glaucoma by targeting and removing fibrillar aggregates associated with exfoliation syndrome
Crichton A
Journal of nanobiotechnology 2022; 20: 459
106451 Immune modulating nanoparticles for the treatment of ocular diseases
Liu Z
Journal of nanobiotechnology 2022; 20: 496
106177 Towards preventing exfoliation glaucoma by targeting and removing fibrillar aggregates associated with exfoliation syndrome
Damji KF
Journal of nanobiotechnology 2022; 20: 459
106451 Immune modulating nanoparticles for the treatment of ocular diseases
Zhou H
Journal of nanobiotechnology 2022; 20: 496
106177 Towards preventing exfoliation glaucoma by targeting and removing fibrillar aggregates associated with exfoliation syndrome
Unsworth LD
Journal of nanobiotechnology 2022; 20: 459

Issue 23-3

Change Issue


advertisement

Oculus